China Pharma Holdings (CPHI) Other Accumulated Expenses (2019 - 2023)

China Pharma Holdings' Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $1.1 million for Q4 2023.

• Quarterly Other Accumulated Expenses fell 54.21% year-over-year to $1.1 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1.1 million (down 54.21% YoY) and the FY2023 annual result came in at $1.1 million, down 54.21% from the prior year.
• Other Accumulated Expenses was $1.1 million for Q4 2023 at China Pharma Holdings, up from $1.1 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $3.1 million in Q3 2021 and bottomed at $1.1 million in Q3 2023.
• A 5-year average of $2.3 million and a median of $2.5 million in 2022 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2021 — Other Accumulated Expenses soared 30.23% — and 2023, when it sank 54.69%.
• China Pharma Holdings' Other Accumulated Expenses stood at $2.1 million in 2019, then climbed by 3.01% to $2.1 million in 2020, then surged by 30.23% to $2.8 million in 2021, then decreased by 10.93% to $2.5 million in 2022, then plunged by 54.21% to $1.1 million in 2023.
• Business Quant data shows CPHI's Other Accumulated Expenses at $1.1 million in Q4 2023, $1.1 million in Q3 2023, and $2.5 million in Q2 2023.